نتایج جستجو برای: drug utilization

تعداد نتایج: 704263  

Journal: :international journal of hematology-oncology and stem cell research 0
sarah mousavi department of clinical pharmacy and pharmacy practice, faculty of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran mina dadpoor pharm d student, faculty of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran farzaneh ashrafi hematology and medical oncology department, school of medicine, isfahan university of medical sciences, isfahan, iran acquired immunodeficiency research center, isfahan university of medical sciences, isfahan, iran

background: granulocyte colony stimulating factors (gcsf) are high cost agents commonly recommended for primary and secondary prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia. gcsfs have been shown to be beneficial in some patient subgroups, although they are probably overused in clinical settings. the american society of clinical oncology (asco) guidelines summarize curr...

Journal: :Journal of managed care pharmacy : JMCP 2004
Thomas R Fulda Alan Lyles Mark C Pugh Dale B Christensen

BACKGROUND The Omnibus Budget Reconciliation Act of 1990 offered the promise that prospective drug utilization review (pDUR) systems would improve the quality of drug prescribing and patient drug use. There is little evidence that this promise has been fulfilled. To the contrary, there is growing evidence that suboptimal use of drugs (in terms of preventable drug-related morbidity) is at least ...

Journal: :JAMA 2003
Sean Hennessy Warren B Bilker Lan Zhou Anita L Weber Colleen Brensinger Yanlin Wang Brian L Strom

CONTEXT Retrospective drug utilization review is required of all state Medicaid programs and is performed by most private-sector prescription programs. However, it has not been shown to improve clinical outcomes or reduce the rate of potential prescribing errors, known as "exceptions." OBJECTIVE To look for an effect of retrospective drug utilization review on the rate of exceptions and of cl...

Journal: :The New England journal of medicine 1995
S B Soumerai H L Lipton

2004
Carl D. Tepper Terry R. Lied

The findings show that with the development of a multitude of safe and effective drugs during the later part of the 20th century and the beginning of the 21st century, drugs are, as never before, a true mainstay of medical treatment. CMS continues to monitor drug utilization and expenditures in all of its programs in order to ensure that care is rendered in a cost-effective manner that is benef...

2014
Giang Binh Tran Jens Grivolla Cosmin Cabulea Claudia Orellana

Grant Agreement nr 611057 Project acronym EUMSSI Start date of project (dur.) December 1st 2013 (36 months) Document due Date : 31 May 2014 Actual date of delivery 6 June 2014 Leader LUH Reply to [email protected] Document status Submitted

Journal: :Chemical communications 2012
Holger Braunschweig Qing Ye Krzysztof Radacki

High yield synthesis of trans-[(Me(3)P)(OC)(3)Fe = BDur] (Dur, "Duryl" = 2,3,4,6-Me(4)C(6)H) is achieved by salt elimination and subsequent liberation of trimethylsilylbromide from K[Fe(CO)(3)(PMe(3))SiMe(3)] and Br(2)BDur.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید